Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes
Journal of Cardiac Failure · 2026-05 · 32 (5) · 821-823
DOI: 10.1016/j.cardfail.2026.02.021 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Cardiac Failure, 2026-05. Verfasst von Joban Vaishnav und 1 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Hospital, Baltimore Maryland. Electronic address: jvaishn1@jhmi.edu. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Johns Hopkins Hospital, Baltimore Maryland. Electronic address: jvaishn1@jhmi.edu.
- Medical University of South Carolina, Charleston, South Carolina.
Zitieren
APA
Vaishnav, J., & Griffin, J. M. (2026). Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes. Journal of Cardiac Failure, 32(5), 821-823. https://doi.org/10.1016/j.cardfail.2026.02.021
Vancouver
Vaishnav J, Griffin JM. Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes. Journal of Cardiac Failure. 2026;32(5):821-823. doi:10.1016/j.cardfail.2026.02.021
BibTeX
@article{Vaishnav2026,
author = {Vaishnav, Joban and Griffin, Jan M},
title = {Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes},
journal = {Journal of Cardiac Failure},
year = {2026},
volume = {32},
number = {5},
pages = {821--823},
doi = {10.1016/j.cardfail.2026.02.021}
}
EUVIMED